Related Experiment Video
Updated: May 5, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome Following Neoadjuvant Chemotherapy for
1Obstetrics and Gynaecology, Celje General Hospital, Celje, SVN.
Abstract:
Hemolytic uremic syndrome (HUS) is an uncommon but serious cause of thrombotic microangiopathy (TMA) in adults and can pose diagnostic challenges, especially in patients receiving chemotherapy, due to overlapping features with chemotherapy-induced TMA. We report the case of a 55-year-old woman with advanced ovarian cancer undergoing neoadjuvant chemotherapy who developed Shiga toxin-producing Escherichia coli (STEC)-associated HUS. The patient developed severe oligo-anuric acute kidney injury (AKI), requiring hemodialysis and multiple transfusions. Early recognition, prompt supportive care, and multidisciplinary management were critical for stabilization and safe continuation of oncologic therapy. This case highlights the importance of considering STEC-HUS in immunocompromised adults presenting with TMA during oncologic chemotherapy.
More Related Videos
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
06:20Detection of Enterohemorrhagic Escherichia Coli Colonization in Murine Host by Non-invasive In Vivo Bioluminescence System
Published on: April 9, 2018
Related Concept Videos
Bacterial Gastroenteritis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Cholera